Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.
Press releases published on June 11, 2025
Aterian’s PurSteam and Mueller Living Brands Launch Products in Walmart Stores
GlobeNewswire
·
June 11, 2025
SUMMIT, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the national launch of two of its most innovative home appliances - the PurSteam Steam Station Max and the Mueller Living Cordless …
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
GlobeNewswire
·
June 11, 2025
PALM BEACH, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates there …
Draganfly Announces Pricing of US$13.75 Million Public Offering
GlobeNewswire
·
June 11, 2025
Saskatoon, SK., June 11, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the pricing of its public offering (the “Offering”) of 5,500, …
TruGolf Announces Acquisition of mlSpatial
GlobeNewswire
·
June 11, 2025
Salt Lake City, Utah, June 11, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, has announced that it has executed a definitive agreement to acquire mlSpatial, a renowned AI and machine learning engineering …
Artelo Biosciences Announces Reverse Stock Split
GlobeNewswire
·
June 11, 2025
SOLANA BEACH, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …
OKYO Pharma to Present at the Bio International Convention
GlobeNewswire
·
June 11, 2025
LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA …
AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough Burn and Sepsis Research
GlobeNewswire
·
June 11, 2025
SAN ANTONIO, Texas and DENVER, Colorado, June 11, 2025 (GLOBE NEWSWIRE) -- The Autonomous Reanimation and Evacuation (AREVA) Research Institute and SeaStar Medical (Nasdaq: ICU) announced today that a new United States Department of Defense (DoD) grant has …
Telos Corporation Secures Multi-Million Dollar Contract Renewal with U.S. Air Force
GlobeNewswire
·
June 11, 2025
ASHBURN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced a contract extension with the U.S. …
Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
GlobeNewswire
·
June 11, 2025
FLORHAM PARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced initial results …
In Rare Double Win Optimal Dynamics Brings Home Two 2025 SupplyTech Breakthrough Awards For “Fleet Management Company of the Year” and “AI-based SupplyTech Solution of the Year”
GlobeNewswire
·
June 11, 2025
LOS ANGELES, June 11, 2025 (GLOBE NEWSWIRE) -- SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products and services in the supply chain technology and logistics …
OSS’s BRESSNER Receives the 2024 EMEA Growth Partner of the Year Award from Digi International
GlobeNewswire
·
June 11, 2025
ESCONDIDO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS) today announced that its subsidiary, BRESSNER Technology GmbH, a leading specialized high-performance computing supplier in Europe, has been …
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
June 11, 2025
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has …
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
GlobeNewswire
·
June 11, 2025
SYDNEY, June 11, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, …
Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
GlobeNewswire
·
June 11, 2025
-- PCRX-201 demonstrated sustained clinical efficacy with improvements in pain, stiffness, and function for up to three years – BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery …
ImmuneWalk Therapeutics Announces Positive Topline Phase 1 SAD Data for Immunology and Inflammation Drug Candidate IW-601
GlobeNewswire
·
June 11, 2025
Study met primary endpoint of safety and tolerability at all doses and secondary pharmacodynamic and pharmacokinetic endpoints after single subcutaneous administration Pharmacodynamics provides mechanistic validation, demonstrating dose-dependent binding …
Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
GlobeNewswire
·
June 11, 2025
GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing precision treatments for addiction and related disorders, today …
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
GlobeNewswire
·
June 11, 2025
ALAMEDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of Anthony …
Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders
GlobeNewswire
·
June 11, 2025
Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disorders Agreement is built on a partnership initiated in 2022, supporting continued development led by positive …
Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
GlobeNewswire
·
June 11, 2025
—Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC— —Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential Strategic Partners Continue— TEL AVIV, Israel, June 11, 2025 ( …
RTI Connext Receives Industry Recognition as Leading Data Platform for Autonomous Systems
GlobeNewswire
·
June 11, 2025
SUNNYVALE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Real-Time Innovations (RTI), the software framework company for physical AI systems, today announced that RTI Connext® has been selected as the winner of the Top Unmanned Systems Data Processing and …